MiR-124-3p reduces angiotensin II-dependent hypertension by down-regulating EGR1.

Lv, Lingchun; Shen, Jiayi; Xu, Jian; Wu, Xiaoyan; Zeng, Chunlai; Lin, Li; Mao, Wei; Wei, Tiemin

Lv, Lingchun; Shen, Jiayi; Xu, Jian; Wu, Xiaoyan; Zeng, Chunlai; Lin, Li; Mao, Wei; Wei, Tiemin.

Afiliação

Lv L; Department of Cardiovascular Medicine, Lishui Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Shen J; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Xu J; Department of Cardiovascular Medicine, Lishui Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wu X; Lishui Cardiovascular Clinical Research Center, Zhejiang Chinese Medical University, Hangzhou, China.
Zeng C; Department of Cardiovascular Medicine, Lishui Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lin L; Department of Cardiovascular Medicine, Lishui Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Mao W; Department of Cardiovascular Medicine, Lishui Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wei T; Lishui Cardiovascular Clinical Research Center, Zhejiang Chinese Medical University, Hangzhou, China.

J Hum Hypertens ; 35(8): 696-708, 2021 08.

Article em En | MEDLINE | ID: mdl-32709884

Assuntos

Hipertensão; MicroRNAs; Angiotensina II/farmacologia; Apoptose; Proteína 1 de Resposta de Crescimento Precoce/genética; Células Endoteliais da Veia Umbilical Humana; Humanos; Hipertensão/induzido quimicamente; Hipertensão/genética; MicroRNAs/genética

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: MicroRNAs / Hipertensão Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Hum Hypertens Assunto da revista: ANGIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google